View in EDS

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Authors: Henderson, Michael A1,2 michael.henderson@petermac.org, Burmeister, Bryan H3, Ainslie, Jill4, Fisher, Richard5, Di Iulio, Juliana5, Smithers, B Mark3, Hong, Angela6, Shannon, Kerwin6, Scolyer, Richard A6, Carruthers, Scott7, Coventry, Brendon J7, Babington, Scott8, Duprat, Joao9, Hoekstra, Harald J10, Thompson, John F6
Source: Lancet Oncology. Sep2015, Vol. 16 Issue 9, p1049-1060. 12p.
Database: Academic Search Ultimate
Description
ISSN:14702045
DOI:10.1016/S1470-2045(15)00187-4